by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerForm 483sAkorn, Inc.

Akorn, Inc.

Form 483

Illinois, United StatesFEI 1450114Issued November 22, 2016

View Form 483 PDF

Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1450114.

Observations6

Issue DateNovember 22, 2016

Status1 Related Warning Letter

Establishment TypeDrug Manufacturer

Related Inspections0

Establishment Details

Firm: Akorn, Inc.
Location: Illinois, United States
FEI Number: 1450114
Establishment Type: Drug Manufacturer
Product Type: Drugs
Issue Date: November 22, 2016
Country: United States

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Akorn, Inc. FDA Form 483, Illinois, November 22, 2016